Search Results - "Jerome, Mary"

Pilot Phase II Study of Metronomic Chemotherapy in Combination with Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer by Jones, Benjamin S, Jerome, Mary S, Miley, Deborah, Jackson, Bradford E, DeShazo, Mollie R, Reddy, Vishnu V.B, Singh, Karan P, Brown, Olivia C, Robert, Francisco

“…Highlights • Metronomic chemotherapy appears tolerable and effective treatment strategy. • Improved PFS and OS. • Plasma biomarkers could potentially…”
Get full text

Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients by Madan, Ankit, Jones, Benjamin S., Bordoni, Rodolfo, Saleh, Mansoor N., Jerome, Mary S., Miley, Deborah K., Jackson, Bradford E., Robert, Francisco

“…Purpose Given the success of cabazitaxel in patients with prostate cancer who progressed after receiving prior chemotherapy, its preclinical efficacy in…”
Get full text

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma by Jamil, Muhammad Omer, Jerome, Mary S, Miley, Deborah, Selander, Katri S, Robert, Francisco

“…Malignant pleural mesothelioma (MPM) is a rare malignancy with a dismal median survival of <12 months with current therapy. Single and combination chemotherapy…”
Get full text

Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC) by Allendorf, Daniel J., Bordoni, Rodolfo E., Grant, Stefan C., Saleh, Mansoor N., Reddy, Vishnu B., Jerome, Mary L., Dixon, Pamela M., Miley, Deborah K., Singh, Karan P., Robert, Francisco

“…Purpose The sequence bendamustine (B) + Irinotecan (I) followed by etoposide (E) + carboplatin (C) was hypothesized to increase progression-free survival (PFS)…”
Get full text

Color stability of aligner materials on exposure to indigenous food products: An in-vitro study by Venkatasubramanian, Priyanka, Jerome, Mary Sanjana, Ragunanthanan, Lokamithra, Maheshwari, Uma, Vijayalakshmi, Devaki

“…In the recent day, there has been an exponential growth in the usage of clear aligners for orthodontic treatment. As with any removable appliance, the…”
Get full text

'Displaced in the name of Religion': Girl child abuse and community healthcare workers' response to women crying for help in IDP camps in North Central, Nigeria by Uroko, Favour Chukwuemeka, Obiorah, Mary Jerome

“…This study examines girl child abuse in an internally displaced people's camp in north-central Nigeria and the response of community health workers. The…”
Get full text

Centronuclear myopathy in Labrador retrievers: a recent founder mutation in the PTPLA gene has rapidly disseminated worldwide by Maurer, Marie, Mary, Jérôme, Guillaud, Laurent, Fender, Marilyn, Pelé, Manuel, Bilzer, Thomas, Olby, Natasha, Penderis, Jacques, Shelton, G Diane, Panthier, Jean-Jacques, Thibaud, Jean-Laurent, Barthélémy, Inès, Aubin-Houzelstein, Geneviève, Blot, Stéphane, Hitte, Christophe, Tiret, Laurent

“…Centronuclear myopathies (CNM) are inherited congenital disorders characterized by an excessive number of internalized nuclei. In humans, CNM results from ~70…”
Get full text

A phase 1b, open label, single institution trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors by Madan, Ankit, Jones, Benjamin Scott, Paluri, Ravi Kumar, Jerome, Mary, Miley, Debi, Robert, Francisco

“…Abstract only TPS2614 Background: Vascular endothelial growth factor (VEGF) is a potent factor in inducing angiogenesis. VEGF inhibitors have produced…”
Get full text

Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors by Paluri, Ravi Kumar, Li, Peng, Jones, Benjamin Scott, Madan, Ankit, Jerome, Mary, Miley, Debi, Keef, Jennifer, Robert, Francisco

“…Abstract only…”
Get full text

Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors by Paluri, Ravi, Madan, Ankit, Li, Peng, Jones, Benjamin, Saleh, Mansoor, Jerome, Mary, Miley, Deborah, Keef, Jennifer, Robert, Francisco

“…Purpose Vascular endothelial growth factor (VEGF) inhibitors have produced demonstrable but limited benefit for various cancers. One mechanism of resistance…”
Get full text

The Theological Impact of a Contextual Interpretation of Sacred Scripture in Nigeria by Obiorah, Mary Jerome, Uroko, Favour C.

“…The profuse use of the Bible perceived as the Word of God and the deposit of faith is common to all Christian denominations in Nigeria. Its contextual…”
Get full text

A phase I feasability study of concurrent fondaparinux (F) with carboplatin (Crb) and paclitaxel (P) for metastatic non-small cell lung cancer (NSCLC): An analysis of coagulation/angiogenic biomarker (CABM) kinetics by Mooney, David James, Miley, Debi, Jerome, Mary, Grant, Stefan C., Robert, Francisco

“…Abstract only e19143 Background: There is an association between risk of thrombosis and metastatic cancer. Chemotherapy (C) also independently increases…”
Get full text

Phase II study of metronomic chemotherapy (MC) with bevacizumab (B) in patients (Pts) with advanced (Adv) nonsquamous non-small cell lung cancer (NS-NSCLC) by Marquette, Carrie Lee, Grant, Stefan C., DeShazo, Mollie, Reddy, Vishnu, Cantor, Alan, Miley, Debi, Jerome, Mary, Robert, Francisco

“…Abstract only 8057 Background: Targeting vascular endothelial growth factor (VEGF) has shown modest improvement in pts with adv NS-NSCLC. The incorporation…”
Get full text

Phase II study of cabazitaxel as second-line therapy in stage IV non-small cell lung cancer (NSCLC) by Das, Devika, Robert, Francisco, Bordoni, Rodolfo, Grant, Stefan C., Saleh, Mansoor N., Reddy, Vishnu, Jerome, Mary, Miley, Debi, Singh, Karan P.

“…Abstract only…”
Get full text

Phase I/IIa study of the novel combination of bendamustine (B) with irinotecan (I) followed by etoposide (E) and carboplatin (C) in untreated patients (Pts) with extensive-stage small cell lung cancer (ESSCLC) by Allendorf, Daniel Joseph, Bordani, Rodolfo, Grant, Stefan C., Saleh, Mansoor N., Jerome, Mary, Miley, Debi, Cantor, Alan, Reddy, Vishnu, Robert, Francisco

“…Abstract only 7591 Background: Standard therapy for ESSCLC consisting of E and a platin drug (Plat) yields a median time to progression (TTP) of 4 months (m)…”
Get full text

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma by Jamil, Muhammad Omer, Jerome, Mary S, Miley, Deborah, Selander, Katri S, Robert, Francisco

“…Purpose: Malignant pleural mesothelioma (MPM) is a rare malignancy with a dismal median survival of <12 months with current therapy. Single and combination…”
Get full text

DATA EXPLORER by Jerome, Mary M.

“…Jerome reviews Data Explorer, a mathematics CD-ROM from Sunburst Communications…”
Get full text

THE DISTANCE GAME by Jerome, Mary M.

“…Jerome reviews Mathematics Learning's Distance Game, developed by Grayson Wheatley and Michael Naylor. This computer game introduces students to a coordinate…”
Get full text

Prevalence of the MYBPC3-A31P mutation in a large European feline population and association with hypertrophic cardiomyopathy in the Maine Coon breed by Mary, Jérôme, Chetboul, Valérie, Sampedrano, Carolina Carlos, Abitbol, Marie, Gouni, Vassiliki, Trehiou-Sechi, Emilie, Tissier, Renaud, Queney, Guillaume, Pouchelon, Jean-Louis, Thomas, Anne

“…The MYBPC3-A31P mutation has been identified in the USA in a colony of Maine Coon cats with an autosomal dominant hypertrophic cardiomyopathy (HCM). The…”
Get full text

The impact of an academic program review on faculty: A mid-process assessment by Jerome, Mary Reinbold

“…As academic program reviews have become the norm in evaluating both institutions of higher education and programs within these institutions, there is a…”
Get full text